Bio-Connect
GTX635679 ELISA Image
GTX635679 ELISA Image
GTX635679 ELISA Image

SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]

Research Use Only
GTX635679
GeneTex
Product group Antibodies
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]
  • Delivery Days Customer
    9
  • Certification
    Research Use Only
  • Clone ID
    HL344
  • Concentration
    1 mg/ml
  • Isotype
    IgG
  • Storage Instruction
    2°C to 8°C,-20°C
  • UNSPSC
    12352203

References

  • Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients. Ruetalo N et al., 2021 Feb 24, mSphere
    Read more
  • Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing. Tsuji K et al., 2021, J Toxicol Sci
    Read more
  • Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. Asaka MN et al., 2021 Oct 8, JCI Insight
    Read more
  • Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target. Garcia-Dorival I et al., 2021 Oct, Antiviral Res
    Read more
  • Neuroinvasion of SARS-CoV-2 in human and mouse brain. Song E et al., 2020 Sep 8, bioRxiv
    Read more
  • Neuroinvasion of SARS-CoV-2 in human and mouse brain. Song E et al., 2021 Mar 1, J Exp Med
    Read more
  • Pharmacological activation of STING blocks SARS-CoV-2 infection. Li M et al., 2021 May 18, Sci Immunol
    Read more
  • SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. Sasaki M et al., 2021 Aug 31, mBio
    Read more
  • SARS-CoV-2 targets neurons of 3D human brain organoids. Ramani A et al., 2020 Oct 15, EMBO J
    Read more
  • Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L. Sacco MD et al., 2020 Jul 27, bioRxiv
    Read more